Wellness Wire Kansas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Wire Kansas.

Press releases published on October 1, 2026

5 hours ago

Agomab Reports Positive Topline Data from STENOVA Open-Label Extension Study of Ontunisertib in Fibrostenosing Crohn's Disease

Indeterminate GlobeNewswire

5 hours ago

Nxera Announces Successful Resolution of miniG Patent Infringement Action

Indeterminate GlobeNewswire

6 hours ago

RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals

Indeterminate GlobeNewswire

6 hours ago

Kestra Medical Technologies Earns Five-Star Rating on Newsweek’s List of America’s Greatest Mid-Market Companies

Indeterminate GlobeNewswire

6 hours ago

Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development

Indeterminate GlobeNewswire

7 hours ago

Allogenetics Appoints Dr. Olaf Schermeier as Chairman of the Advisory Board

Indeterminate GlobeNewswire

8 hours ago

Atrogi announces positive human data for ATR-258, its first-in-class, oral therapy designed to improve muscle function and body composition

Indeterminate GlobeNewswire

8 hours ago

Numab Therapeutics Appoints Dr. Rajesh Chopra as Chief Scientific Officer to Advance its Proprietary Multispecific Antibody Pipeline

Indeterminate GlobeNewswire

8 hours ago

DaltonTx, the decision engine for drug discovery, launches advanced AI-powered antibody discovery platform

Indeterminate GlobeNewswire

8 hours ago

Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes

Indeterminate GlobeNewswire

8 hours ago

Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes

Indeterminate GlobeNewswire

9 hours ago

SkinHealth Systems bringt das SkinStylus® SteriLock® MicroSystem auf den europäischen Markt

Indeterminate GlobeNewswire

9 hours ago

SkinHealth Systems Expands SkinStylus® SteriLock® MicroSystem to Europe

Indeterminate GlobeNewswire

9 hours ago

SkinHealth Systems anuncia el lanzamiento europeo de SkinStylus® SteriLock®

Indeterminate GlobeNewswire

9 hours ago

Le SkinStylus® SteriLock MicroSystem de SkinHealth Systems désormais disponible sur le marché européen

Indeterminate GlobeNewswire

10 hours ago

Oculis Joins the National Multiple Sclerosis Society’s Campaign to End MS

Indeterminate GlobeNewswire

10 hours ago

Mironid successfully doses initial cohorts in Phase 1 clinical trial investigating the Company’s first-in-class LoAc® small molecule for patients with ADPKD

Indeterminate GlobeNewswire

11 hours ago

Press Release: Sanofi and Regeneron expand global Alliance with multiple next-generation, long-acting immunology antibodies

Indeterminate GlobeNewswire

11 hours ago

Communiqué de presse : Sanofi et Regeneron élargissent leur Alliance mondiale avec plusieurs anticorps immunologiques de nouvelle génération à action prolongée

Indeterminate GlobeNewswire

11 hours ago

Regeneron and Sanofi Expand Global Alliance with Multiple Next-Generation, Long-Acting Immunology Antibodies

Indeterminate GlobeNewswire